The requirements for FDA 21 CFR Part 11 are in place for a good reason: When companies are making a part that goes inside your body, the engineering and manufacturing process must be meticulously documented, tested and controlled. People’s lives are at stake.
Aging assets have long been the culprits behind common supply chain disruptions like unexpected downtime and production delays. They can have a direct impact on revenues and service levels, and the older they get, the more costly the risks they pose are.
Business France will in March wrap up its first accelerator “dedicated to the industry of the future in North America.” The 10-month program is specialized in monitoring and control tech, as well as data analytics.
